Advertisement
Screener

PMV PHARMACEUTICALS, INC. (PMVP) Current State and Local Tax Expense (Benefit)

1.4 / 5 stars · 10/36 Roast Me

PMV PHARMACEUTICALS, INC. Current State and Local Tax Expense (Benefit)

PMV PHARMACEUTICALS, INC. (PMVP) reported Current State and Local Tax Expense (Benefit) of -$2.19 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-06.

Financial Statements › Expense Statement › Income Tax

us-gaap:CurrentStateAndLocalTaxExpenseBenefit · last filed 2026-03-06

  • PMV PHARMACEUTICALS, INC. current state and local tax expense (benefit) for fiscal 2025 was -$2.19M.
  • PMV PHARMACEUTICALS, INC. current state and local tax expense (benefit) for fiscal 2024 was -$16.17M, a 808600.00% decline from fiscal 2023.
  • PMV PHARMACEUTICALS, INC. current state and local tax expense (benefit) for fiscal 2023 was $2.00K.
  • PMV PHARMACEUTICALS, INC. current state and local tax expense (benefit) for fiscal 2022 was -$9.00K, a 139.13% decline from fiscal 2021.
Period endCurrent State and Local Tax Expense (Benefit) 12 month
2025-12-31-$2.19M
10-K · filed 2026-03-06
2024-12-31-$16.17M
10-K · filed 2026-03-06
2023-12-31$2.00K
10-K · filed 2026-03-06
2022-12-31-$9.00K
10-K · filed 2025-03-03
2021-12-31$23.00K
10-K · filed 2024-02-29
2020-12-31$6.00K
10-K · filed 2023-03-01
2019-12-31$8.00K
10-K · filed 2022-03-01
2018-12-31$3.00K
10-K · filed 2021-03-03

Similar stocks

Stock NameCountryMarket CapPE Ratio
TENAX THERAPEUTICS, INC. (TENX)United States$0.071B-7.17
Lunai Bioworks Inc. (LNAI)United States$0.072B-0.11
PLIANT THERAPEUTICS, INC. (PLRX)United States$0.071B-0.76
Yarrow Bioscience, Inc. (YARW)United States$0.070B
Spero Therapeutics, Inc. (SPRO)United States$0.073B17.41
Cingulate Inc. (CING)United States$0.073B-2.64
Connect Biopharma Holdings Ltd (CNTB)$0.069B-2.17
Aldeyra Therapeutics, Inc. (ALDX)United States$0.074B-5.57
OS Therapies Inc (OSTX)United States$0.076B-2.17
Verrica Pharmaceuticals Inc. (VRCA)United States$0.076B-3.39